Please provide your email address to receive an email when new articles are posted on . Pregnant women treated with regimens including bedaquiline and/or delamanid had positive treatment outcomes.

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

(RTTNews) - Johnson & Johnson (JNJ), a global health care company, has received full approval from the US FDA and the European Commission for Sirturo (bedaquiline), a treatment specifically designed ...

(Boston) – Tuberculosis (TB) disproportionately affects vulnerable populations including those with limited economic resources, HIV patients, those whose diet is deficient in nutrients and others.

There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

Please provide your email address to receive an email when new articles are posted on . Two phase 3 trials showed levofloxacin reduces the risk for multidrug-resistant TB after household exposure.

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant tuberculosis (TB) bacteria in the test tube, according to a new study. The ...

An outbreak of multidrug-resistant tuberculosis (TB) developed in Kansas in November 2021, and included multiple children who were born in the U.S. and became infected in the state, CDC researchers ...